关注
देवेश तिवारी, Devesh Tewari
देवेश तिवारी, Devesh Tewari
Delhi Pharmaceutical Sciences and Research University (DPSRU)
在 dpsru.edu.in 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
M Mehta, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ...
Chemico-biological interactions 308, 206-215, 2019
7582019
Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
D Tewari, P Patni, A Bishayee, AN Sah, A Bishayee
Seminars in cancer biology 80, 1-17, 2022
3622022
Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
X Feng, A Sureda, S Jafari, Z Memariani, D Tewari, G Annunziata, ...
Theranostics 9 (7), 1923-1951, 2019
2972019
Curcumin, the golden spice in treating cardiovascular diseases
H Li, A Sureda, HP Devkota, V Pittalà, D Barreca, AS Silva, D Tewari, ...
Biotechnology advances 38, 107343, 2020
2802020
Review on nanoparticles and nanostructured materials: Bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-food applications
V Harish, D Tewari, M Gaur, AB Yadav, S Swaroop, M Bechelany, ...
Nanomaterials 12 (3), 457, 2022
2782022
Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery
N Zahin, R Anwar, D Tewari, MT Kabir, A Sajid, B Mathew, MS Uddin, ...
Environmental Science and Pollution Research 27 (16), 19151-19168, 2020
2662020
Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems
M Hajialyani, D Tewari, E Sobarzo-Sánchez, SM Nabavi, MH Farzaei, ...
International journal of nanomedicine, 5023-5043, 2018
1942018
Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
D Tewari, SF Nabavi, SM Nabavi, A Sureda, AA Farooqi, AG Atanasov, ...
Pharmacological Research 128, 366-375, 2018
1842018
The role of flavonoids in autoimmune diseases: Therapeutic updates
KRR Rengasamy, H Khan, S Gowrishankar, RJL Lagoa, ...
Pharmacology & therapeutics 194, 107-131, 2019
1562019
Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs
D Tewari, AM Stankiewicz, A Mocan, AN Sah, NT Tzvetkov, L Huminiecki, ...
Frontiers in aging neuroscience 10, 3, 2018
1512018
Circadian and sleep dysfunction in Alzheimer’s disease
MS Uddin, D Tewari, A Al Mamun, MT Kabir, K Niaz, MII Wahed, ...
Ageing Research Reviews 60, 101046, 2020
1312020
Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease
MS Uddin, D Tewari, G Sharma, MT Kabir, GE Barreto, MN Bin-Jumah, ...
Molecular Neurobiology 57, 2902-2919, 2020
1252020
Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches
MS Uddin, A Al Mamun, BS Alghamdi, D Tewari, P Jeandet, MS Sarwar, ...
Seminars in cancer biology 83, 100-120, 2022
1202022
Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways
D Wang, P Uhrin, A Mocan, B Waltenberger, JM Breuss, D Tewari, ...
Biotechnology advances 36 (6), 1586-1607, 2018
1132018
Anthocyanins in the management of metabolic syndrome: A pharmacological and biopharmaceutical review
R Naseri, F Farzaei, P Haratipour, SF Nabavi, S Habtemariam, ...
Frontiers in Pharmacology 9, 1310, 2018
1012018
Role of nitric oxide in neurodegeneration: function, regulation, and inhibition
D Tewari, AN Sah, S Bawari, SF Nabavi, AR Dehpour, S Shirooie, ...
Current neuropharmacology 19 (2), 114-126, 2021
1002021
Down syndrome: Neurobiological alterations and therapeutic targets
RA Vacca, S Bawari, D Valenti, D Tewari, SF Nabavi, S Shirooie, AN Sah, ...
Neuroscience & Biobehavioral Reviews 98, 234-255, 2019
902019
Nanoparticle and nanostructure synthesis and controlled growth methods
V Harish, MM Ansari, D Tewari, M Gaur, AB Yadav, ML García-Betancourt, ...
Nanomaterials 12 (18), 3226, 2022
852022
Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families
D Tewari, A Mocan, ED Parvanov, AN Sah, SM Nabavi, L Huminiecki, ...
Frontiers in pharmacology 8, 519, 2017
822017
Big impact of nanoparticles: Analysis of the most cited nanopharmaceuticals and nanonutraceuticals research
AWK Yeung, EB Souto, A Durazzo, M Lucarini, E Novellino, D Tewari, ...
Current research in Biotechnology 2, 53-63, 2020
812020
系统目前无法执行此操作,请稍后再试。
文章 1–20